Anti-impotence drug sets off war among competitors

Competition is about to heat up in the domestic anti-impotence drug market, as Bayer Korea and Chong Kung Dang Pharmaceutical, like the successful strategic alliance of Lilly Korea and Daewoong Pharm, finally agreed to co-market Levitra for a bigger share of the nation's growing erectile dysfunction medicine market.

Since Dong-A Pharmaceutical introduced its anti-impotence drug named Zydena ...